BioCryst Pharmaceuticals Inc
SWB:BO1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BioCryst Pharmaceuticals Inc
SWB:BO1
|
US |
|
J
|
Johnson Matthey PLC
XBER:JMT2
|
UK |
|
United States Lime & Minerals Inc
F:ULI
|
US |
|
S
|
Spark New Zealand Ltd
XBER:NZTA
|
NZ |
|
Minda Corporation Ltd
NSE:MINDACORP
|
IN |
|
T
|
Talgo SA
SWB:XTG
|
ES |
|
Indiva Ltd
XTSX:NDVA
|
CA |
|
S
|
Sega Sammy Holdings Inc
XBER:RYU
|
JP |
|
Capgemini SE
XETRA:CGM
|
FR |
|
J
|
JF Technology Bhd
KLSE:JFTECH
|
MY |
|
Controladora Vuela Compania de Aviacion SAB de CV
OTC:CTTRF
|
MX |
|
H
|
Huaneng Power International Inc
XMUN:HUP1
|
CN |
|
Samsara Inc
NYSE:IOT
|
US |
|
W
|
Webjet Ltd
OTC:WEBJF
|
AU |
|
S
|
Spark New Zealand Ltd
F:NZT
|
NZ |
|
K
|
Kongsberg Automotive ASA
XBER:K3A
|
NO |
|
Coastal Corporation Ltd
BSE:501831
|
IN |
|
V
|
VivoPower International PLC
F:51J
|
US |
|
B
|
Bastogi SpA
F:BAOA
|
IT |
|
T
|
TG Metals Ltd
ASX:TG6
|
AU |
|
C
|
City of London Investment Group PLC
LSE:CLIG
|
UK |
|
A
|
AutoCanada Inc
OTC:AOCIF
|
CA |
|
SFC Energy AG
OTC:SSMFF
|
DE |
|
Bukit Asam Tbk PT
IDX:PTBA
|
ID |
Bankruptcy Probability
BioCryst Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BioCryst Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
|
2.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
150.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BioCryst Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BioCryst Pharmaceuticals Inc has total debt of 803.6m USD. This includes both short-term (0 USD) and long-term (803.6m USD) debt.
You can find a full breakdown on its Balance Sheet.
